Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:CLGNNYSE:INFUNASDAQ:KRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$4.98-3.1%$5.20$2.34▼$8.79$179.40MN/A218,266 shs219,359 shsCLGNCollPlant Biotechnologies$2.24+1.1%$2.85$2.00▼$6.75$25.60M1.3211,162 shs5,443 shsINFUInfuSystem$4.97-0.6%$5.85$4.61▼$9.97$104.45M1.985,986 shs79,295 shsKRMDKORU Medical Systems$2.47-0.8%$2.79$1.86▼$5.05$113.51M0.87140,429 shs133,744 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global0.00%+72.92%+31.05%-17.00%+497,999,900.00%CLGNCollPlant Biotechnologies0.00%-7.64%-12.35%-42.91%-62.05%INFUInfuSystem0.00%+1.22%-9.14%-39.90%-42.01%KRMDKORU Medical Systems0.00%+8.81%-4.63%-40.48%+12.79%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/ACLGNCollPlant Biotechnologies2.3954 of 5 stars3.73.00.00.01.90.01.3INFUInfuSystem1.5014 of 5 stars2.00.00.00.01.12.51.9KRMDKORU Medical Systems3.0615 of 5 stars3.54.00.00.02.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50231.33% UpsideCLGNCollPlant Biotechnologies 3.33Buy$12.50459.28% UpsideINFUInfuSystem 4.00Strong Buy$13.00161.57% UpsideKRMDKORU Medical Systems 3.00Buy$4.7090.28% UpsideCurrent Analyst Ratings BreakdownLatest CLGN, AVR, INFU, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.003/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/13/2025KRMDKORU Medical SystemsB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy2/14/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$4.50 ➝ $4.502/12/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.002/4/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.00(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.71M66.17N/AN/AN/A∞CLGNCollPlant Biotechnologies$515K49.71N/AN/A$2.47 per share0.90INFUInfuSystem$134.86M0.77$0.39 per share12.79$2.47 per share2.01KRMDKORU Medical Systems$33.65M3.37N/AN/A$0.45 per share5.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/ACLGNCollPlant Biotechnologies-$7.02M-$1.46N/AN/AN/A-2,680.00%-77.05%-61.43%5/27/2025 (Estimated)INFUInfuSystem$870K$0.1082.8516.03N/A1.12%2.78%1.41%N/AKRMDKORU Medical Systems-$13.74M-$0.12N/AN/AN/A-37.42%-24.60%-16.87%5/7/2025 (Estimated)Latest CLGN, AVR, INFU, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02N/AN/AN/AN/AN/A3/26/2025Q4 2024CLGNCollPlant Biotechnologies-$0.42-$0.34+$0.08-$0.34$0.36 million$0.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ACLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/AN/AN/ACLGNCollPlant BiotechnologiesN/A5.385.23INFUInfuSystem0.501.981.59KRMDKORU Medical Systems0.012.992.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ACLGNCollPlant Biotechnologies21.69%INFUInfuSystem71.13%KRMDKORU Medical Systems58.60%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/ACLGNCollPlant Biotechnologies9.60%INFUInfuSystem10.20%KRMDKORU Medical Systems20.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.02 millionN/AN/ACLGNCollPlant Biotechnologies7011.46 million10.36 millionOptionableINFUInfuSystem41021.02 million19.10 millionOptionableKRMDKORU Medical Systems8045.96 million34.10 millionOptionableCLGN, AVR, INFU, and KRMD HeadlinesRecent News About These CompaniesTopline Capital Management LLC Purchases Shares of 4,327,164 KORU Medical Systems, Inc. (NASDAQ:KRMD)April 27 at 6:28 AM | marketbeat.comKORU Medical Systems (NASDAQ:KRMD) vs. AtriCure (NASDAQ:ATRC) Head-To-Head ContrastApril 24, 2025 | americanbankingnews.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 5.80%April 23, 2025 | aaii.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 7.49%April 21, 2025 | aaii.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Down 9.22%April 10, 2025 | aaii.comKoru Medical management to meet with Craig-HallumApril 9, 2025 | markets.businessinsider.comKORU Medical Systems, Inc.'s (NASDAQ:KRMD) market cap dropped US$17m last week; individual investors who hold 43% were hit as were institutionsMarch 20, 2025 | finance.yahoo.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comKoru Medical reports Q4 EPS (13c), consensus (2c)March 12, 2025 | markets.businessinsider.comKoru Medical sees FY25 revenue $38M-$39M, consensus $38.4MMarch 12, 2025 | markets.businessinsider.comKORU Medical Systems, Inc. (KRMD): A Bull Case TheoryFebruary 27, 2025 | msn.comKORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025February 19, 2025 | businesswire.comPiper Sandler Downgrades KORU Medical Systems (KRMD)February 15, 2025 | msn.comKORU downgraded by Piper Sandler on valuationFebruary 14, 2025 | msn.comPiper Sandler cuts Koru Medical stock rating to neutralFebruary 14, 2025 | msn.comKoru Medical downgraded to Neutral from Overweight at Piper SandlerFebruary 14, 2025 | markets.businessinsider.comKoru Medical inks deal to develop next-gen subcutaneous infusion systemFebruary 7, 2025 | drugdeliverybusiness.comKoru announces pact for next-gen subcutaneous immunoglobulin infusion systemFebruary 7, 2025 | markets.businessinsider.comKORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion SystemFebruary 6, 2025 | businesswire.comKORU Medical partners for Phase III trial in rare kidney disorderJanuary 30, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLGN, AVR, INFU, and KRMD Company DescriptionsAnteris Technologies Global NASDAQ:AVR$4.98 -0.16 (-3.11%) As of 04/25/2025 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.CollPlant Biotechnologies NASDAQ:CLGN$2.24 +0.03 (+1.13%) Closing price 04/25/2025 03:25 PM EasternExtended Trading$2.24 +0.01 (+0.45%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.InfuSystem NYSE:INFU$4.97 -0.03 (-0.60%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$4.96 -0.01 (-0.30%) As of 04/25/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.KORU Medical Systems NASDAQ:KRMD$2.47 -0.02 (-0.80%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$2.47 0.00 (0.00%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
